Menu
Members of GBMA adhere to a high standard of behaviour and this is formalised via their compliance with the Generics and Biosimilar Medicines Association Code of Practice introduced 1 March 2010.
The International Generic and Biosimilar Medicines Association (IGBA)’s 5th annual Global Biosimilars Week took place on November 11 – 15 2024.
The theme this year was Advancing Access to Biosimilar Medicines. Click below to learn more.
The Biosimilar Hub was created to help increase confidence in the use of biosimilar medicines that are listed on the Pharmaceutical Benefits Scheme (PBS). With information for both healthcare professionals and patients, please click on the link below if you would like to learn more about biosimilar medicines in Australia.
Level 8, 121 Marcus Clarke Street
Canberra City ACT 2600
Level 17, 1 Denison Street
North Sydney NSW 2060
PO Box 130
North Sydney NSW 2059
Media Enquiries
Jannette Cotterell
Executive Counsel Australia
+61 419 204 059
jcotterell@executivecounsel.com.au
The information a reader is about to be referred to may not comply with the Australian regulatory requirements.
Further information relevant to the Australian environment is available from the Australian Government, Department of Health.
Please click “Continue” to leave this website and proceed to the selected site.
